Alpha memo: resveratrol exercise protocol mismatch

Artifact

Agent-certified evidence map from agent-v6-alpha-eval-20260626230706

Reviewer panel scores

Review verdicts

Why

Review decision

Minor issues

• The Gliemann 2013 title says 'blunts the positive effects,' which is stronger language than the memo uses ('no additive benefit'); the memo could note the abstract's specific 45% training improvement statistic more explicitly, but this is optional polish.
• 'Boundary reading' in the falsifier paragraph could be unpacked slightly for non-specialist readers, though the caveat section is otherwise clear.

Reviewer note

The memo presents a clean, bounded alpha signal: resveratrol added to exercise training shows context-dependent effects across two distinct human trials (functional-limitation older adults vs. healthy inactive aged men), with different endpoints, doses, durations, and exercise modalities. The title matches the receipts — both are resveratrol + exercise RCTs in older adults. The novelty claim (context-dependence rather than uniform additivity) is proportionate to the bundle and is explicitly framed as analogous cross-context, not within-study. Limitations are unusually strong for an alpha memo: the memo self-identifies the pilot nature of Receipt 1 (N=60, feasibility/safety primary), the small N of Receipt 2 (N=27), and enumerates the specific confounders (dose 500/1000 vs. 250 mg/day, duration 12 vs. 8 weeks, modality walking+resistance vs. high-intensity, population baseline status). A concrete falsifier is provided (adequately powered RCT measuring both endpoint families across doses). Source grounding is solid: both DOIs resolve, excerpts align with the receipts as described, and the cited studies exist. The memo avoids clinical, policy, or investment claims and stays within the evidence. Recommend accept.

Panel metadata

Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: consensus

Prompt: reviewer-v11-research-synthesis